Code and data employed in the development of the MDS-AML Aggregative Risk Classification System (MARCS). MARCS is a novel risk stratification tool that transcends the MDS-AML dichotomy, offering enhanced accuracy in predicting both survival outcomes and progression to AML.
An open-access web application enables users to access the MARCS classification and stratify new patients. You can access it at https://marcs.ethz.ch/.
M. Roncador, F. Bayer, J. W. Deuel, J. Kuipers, K. Takahashi, M. G. Manz, S. Böttcher, N. Beerenwinkel, S. Balabanov Beyond AML and MDS separation: dissecting the complexity of MDS-AML continuum with the MDS-AML Aggregative Risk Classification System (MARCS) in 7480 patients. Submitted.